Medtronic Appoints Thierry Piéton as Chief Financial Officer
Medtronic plc (NYSE: MDT), a prominent player in the healthcare technology sector, has recently announced the appointment of Thierry Piéton as its Chief Financial Officer (CFO). This strategic decision underscores the company’s commitment to financial excellence and innovation.
Leadership Transition and Experience
Effective March 3, 2025, Piéton will step into the role, reporting directly to Medtronic Chairman and Chief Executive Officer Geoff Martha. Prior to joining Medtronic, Piéton served as CFO at Renault Group, where his leadership was instrumental in achieving record operating margins and enhancing free cash flow.
Significant Contributions at Renault
During his tenure at Renault, Piéton demonstrated his capacity for strategic financial management, overseeing portfolio management initiatives, acquisition efforts, and innovative partnerships that greatly increased shareholder value. His prior experience includes pivotal roles at companies such as Nissan Motor Co. Ltd., General Electric, and GE Healthcare.
Key Responsibilities as CFO
In his new position, Piéton will be at the helm of Medtronic's global finance organization. This includes essential functions such as Treasury, Internal Audit, Investor Relations, and Corporate Strategy. His extensive background in navigating complex financial landscapes will benefit Medtronic's mission to drive growth and improve operational efficiency.
Recognizing Interim CFO Gary Corona
Gary Corona, who has filled the role of interim CFO, is acknowledged for his leadership which led to revenue growth surpassing expectations during his term. After Piéton's arrival, Corona will transition into the role of Senior Vice President of Corporate Finance and will continue being an integral part of Medtronic’s Executive Committee.
About Medtronic
Headquartered in Galway, Ireland, Medtronic stands as a leading global healthcare technology company committed to tackling significant health challenges. With a mission to alleviate pain, restore health, and extend lives, the company employs over 95,000 individuals across 150+ countries. Its innovative technologies address over 70 health conditions, ranging from cardiac devices to surgical robotics and patient monitoring systems.
Innovation and Commitment to Patients
Medtronic’s dedication is reflected in its continuous development of cutting-edge technologies that transform lives. The company is driven by insatiable curiosity and a desire to enhance patient outcomes, striving to deliver the highest quality care while putting people first.
Frequently Asked Questions
Who is the new CFO of Medtronic?
Thierry Piéton has been appointed as the new Chief Financial Officer.
When will Piéton start his new role?
He will officially begin as CFO on March 3, 2025.
What experience does Piéton bring to Medtronic?
Piéton has a strong background in finance, having served as CFO at Renault Group and held significant positions at Nissan, General Electric, and GE Healthcare.
What are Piéton's key responsibilities at Medtronic?
He will lead the global finance organization, overseeing key functions including Treasury, Corporate Strategy, and Investor Relations.
How has Gary Corona contributed to Medtronic?
Gary Corona has served as interim CFO, leading the company to exceed revenue growth expectations during his tenure.
